Keebeck Alpha, LP Abbott Laboratories Transaction History

Keebeck Alpha, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $86,205 - $101,468	-890 Reduced 28.98%	2,181 $220,000
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $297,149 - $344,044	3,071 New	3,071 $297,000
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $266,080 - $340,550	-3,475 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $218,299 - $319,213	3,475 New	3,475 $274,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.